Ex Vivo Expansion of Functional Hematopoietic Stem Cells, Facilitating Transplantation in the Absence of Conditioning [0.03%]
无需预处理即可进行移植的体内扩增功能性造血干细胞技术
Michael D Milsom
Michael D Milsom
MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL) [0.03%]
MYC重排的侵袭性B细胞淋巴瘤：意大利淋巴瘤协会(Fondazione Italiana Linfomi, FIL)报告100例患者分析结果
Maria Chiara Tisi,Simone Ferrero,Irene Dogliotti et al.
Maria Chiara Tisi et al.
Iron-Related Parameters are Altered Between C57BL/6N and C57BL/6J Mus Musculus Wild-Type Substrains [0.03%]
铁相关参数在C57BL/6N和C57BL/6J野生型亚系小鼠中的差异性分析
Oriana Marques,Joana Neves,Natalie K Horvat et al.
Oriana Marques et al.
Low Bone Mineral Density and High Bone Turnover in Patients With Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study [0.03%]
一线治疗非霍奇金淋巴瘤患者的低骨密度和高骨转换：一项多中心前瞻性研究的结果
Konstantinos Anargyrou,Despina Fotiou,Theodoros P Vassilakopoulos et al.
Konstantinos Anargyrou et al.
Chemotherapy associated osteoporosis is a severe problem in patients with malignant diseases as it increases the risk for fractures and deteriorates quality of life. There are very limited data in the literature for the effect of chemothera...
SLN124, a GalNAc-siRNA Conjugate Targeting TMPRSS6, Efficiently Prevents Iron Overload in Hereditary Haemochromatosis Type 1 [0.03%]
新型GalNAc-siRNA缀合物SLN124靶向TMPRSS6高效预防遗传性血色病1型铁过载
Sandro Altamura,Ute Schaeper,Sibylle Dames et al.
Sandro Altamura et al.
Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy [0.03%]
新一代流式细胞术检测维持完全缓解状态的初治多发性骨髓瘤患者微量残留病的影响
Evangelos Terpos,Ioannis V Kostopoulos,Efstathios Kastritis et al.
Evangelos Terpos et al.
Minimal residual disease (MRD) was monitored in 52 patients with sustained CR (≥2 years) after frontline therapy using next-generation flow (NGF) cytometry. 25% of patients initially MRD- reversed to MRD+. 56% of patients in sustained CR w...
Francesca Vinchi,Avital Mendelson,Karina Yazdanbakhsh et al.
Francesca Vinchi et al.
Delivering on the Promise: Innovative Therapies and the Quest for (Real) Patient Benefit [0.03%]
创新疗法与患者获益的追求
Robin Doeswijk
Robin Doeswijk
The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-cell Lymphoma in the Era of CAR-T Cell Therapy [0.03%]
CAR-T细胞治疗时代自体造血干细胞移植在弥漫大B细胞淋巴瘤治疗中作用再评估
Lazaros J Lekakis,Craig H Moskowitz
Lazaros J Lekakis
For many years now and based on the results of the PARMA trial, relapsed Diffuse Large B-cell Lymphoma (DLBCL) is treated with salvage combination cytotoxic chemotherapy (most often platinum-based) followed by high dose myeloablative chemot...
Anas Younes
Anas Younes